Med-In-Pharma 2022 – a commitment to excellence
On November 17-18, the Malta Medicines Authority (MMA) successfully held its first Med-In-Pharma 2022 side-event at the Med-Tech World Summit in Malta.
The MMA is an institution that is self-funded and does not depend on the Maltese taxpayer. Since 2013 it has processed nearly 550 new pharmaceutical licensing procedures as a Reference Member State. It also generates revenue by offering expert regulatory and assessment services to the pharmaceutical industry in Europe, the United States of America, Canada, India, Oman, Serbia, South Africa, China, United Arab Emirates, Ghana, and Turkey. It is no coincidence that the MMA is one of a handful of recognised trusted partners of the US FDA. Its pharmaceutical portfolio is busy and vast and Government recognises its significant contribution to the local industry. That is why the Authority’s original nucleus has been expanded to over 100-strong with further manpower expansion very soon on the way.
The MMA’s appearance on the Med-tech stage is consonant with its newly professed ambition to enlarge its medical device and Notified Body portfolio. This can only strengthen the burgeoning life sciences in our country.
Med-In Pharma 2022...